Local drugmaker AFT Pharmaceuticals has downgraded its earnings forecast because of stalled licensing negotiations and disruptions to its supply chain.
Follow Our Network On LinkedIn: Follow link
Local drugmaker AFT Pharmaceuticals has downgraded its earnings forecast because of stalled licensing negotiations and disruptions to its supply chain.